Interleukin-19 (IL-19) has been shown to be involved in coronary artery diseases and atherosclerosis, while its expression in myocardial infarction is poorly understood . In this study, the dynamic increase in circulating IL-19 in acute ST-segment elevation myocardial infarction (STEMI) patients was detected.

高活性、高纯度、低内毒素、高批间一致性

                                        SDS-PAGE

Human IL-19 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

                                                   HPLC

The purity of Human IL-19 is greater than 95% as determined by SEC-HPLC.

                                                   ELISA Data

Immobilized Human IL-19, hFc Tag at 0.5μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Anti-IL-19 Antibody, hFc Avi Tag with the EC50 of 19.3ng/ml determined by ELISA.

-25~-15℃保存，收到货之日起，有效期1年。复溶后， -85~-65℃保存，3个月有效期。避免反复冻融。